Understanding resilience to Alzheimer's disease in Colombian families with genetic mutations
Resilience to Cognitive Decline and Resistance to Alzheimer's Disease and Related Neurodegenerative Diseases in Individuals from Colombia with Autosomal Dominant Dementias
This study is looking at how specific genetic changes linked to early-onset Alzheimer's disease impact memory and thinking skills in people from Colombia, especially those with these mutations and their family members, to find out what helps some people stay mentally sharp despite the disease.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Massachusetts General Hospital NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project ID | NIH-10721433 on NIH RePORTER |
What this research studies
This research investigates how certain genetic mutations associated with early-onset Alzheimer's disease affect cognitive decline in individuals from Colombia. By studying large families with these mutations, the research aims to identify biological factors that contribute to resilience against dementia. Participants will undergo genetic analysis and cognitive assessments to explore the relationship between genetic variants and neurodegenerative conditions. The study focuses on individuals who carry specific mutations, such as PSEN1, and their relatives, to better understand protective mechanisms against cognitive decline.
Who could benefit from this research
Good fit: Ideal candidates for participation include individuals from Colombian families with known genetic mutations linked to early-onset Alzheimer's disease.
Not a fit: Patients without genetic mutations associated with Alzheimer's disease or those not from the studied Colombian families may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new insights into preventing or delaying the onset of Alzheimer's disease and related dementias.
How similar studies have performed: Previous research has shown success in understanding genetic factors in Alzheimer's disease, making this approach promising and relevant.
Where this research is happening
Boston, United States
- Massachusetts General Hospital — Boston, United States (Active)
Researchers
- Principal investigator: Quiroz, Yakeel T. — Massachusetts General Hospital
- Study coordinator: Quiroz, Yakeel T.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.